Lisa M Butler

46PUBLICATIONS

261CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer cell biologyGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (46)

Sort by Publication Date:

|Jun 02, 2026

USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Apr 03, 2026

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Mar 03, 2026

Connecting the Cell Cycle to Lipid Metabolism in Cancer: Their Reciprocal Roles and Opportunity for Therapeutic Exploitation.

Joshua T Hodgson, Lisa M Butler, Margaret M Centenera

|Dec 03, 2025

Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets.

Jasmine T Plummer, Felipe Segato Dezem, David P Cook

|Nov 27, 2025

Personalized intensification of treatment for hormone-sensitive prostate cancer.

Michael A Cilento, Lisa M Butler, Louise Emmett

Pageof 8

Frequent Collaborators

10 joint publications

Luke A Selth

10 joint publications

Johannes V Swinnen

Andrew J Hoy

Zeyad D Nassar

Ian R D Johnson

David J Lynn

Wayne D Tilley

Jianling Xie

Chui Yan Mah

Julia S Scott

Frequent Collaborators

10 joint publications

Luke A Selth

10 joint publications

Johannes V Swinnen

9 joint publications

Andrew J Hoy

8 joint publications

Zeyad D Nassar